⬡ GrantFinder
Dashboard
Board
SAP Sequence
Scout
Memory
Profile
2026-09-21
← Dashboard
Pipeline:
Profile
→
Scout
→
Research
→
Draft
→
Applied
U.S. Rare Disease Biotech Investing Rises After... | PharmExec
U.S. Rare Disease Biotech Investing Rises After FDA’s PRV Program Renewal: Report
AMBER
Tx
General
Strategy Notes
Keyword match: +2 relevant, -0 negative signals.
Key Materials
—
Your Notes
Save Notes
Status & Deadline
Status
INELIGIBLE
Deadline
—
Cycle
rolling
Amount
—
Type
grant
URL
Apply
Update Status
OPEN
CLOSING SOON
UPCOMING
GATED
CLOSED
APPLIED
REJECTED
AWARDED
SKIPPED
INELIGIBLE
HUMAN_REQUIRED
Update
Log Application
Mark Applied
AI Pipeline
Research Programme
Generate Draft
Auto Apply (Agent)
Preview Application (Dry Run)
Status History
2026-08-12
OPEN → INELIGIBLE
· The page is a news article about the FDA Priority Review Voucher program; no funding application, deadline, or eligibility criteria are provided.